2018-19<\/p><\/td> | 88.0%<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> Source: NHS England and NHS Digital<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-21T13:01:37.37Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Accident and Emergency Departments: Standards"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what proportion of patients were seen within four hours in A&E in (a) 2018-19 and (b) each year since 2010.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4244", "label" : {"_value" : "Biography information for Jonathan Ashworth"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester South"}
, "tablingMemberPrinted" : [{"_value" : "Jonathan Ashworth"}
], "uin" : "1050"}
, {"_about" : "http://data.parliament.uk/resources/1150213", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1150213/answer", "answerText" : {"_value" : " There were a number of issues raised around the appointment process for the Chair of the Blackpool Trust on 27 June 2018. National Health Service foundation trusts operate within a clear accountability framework. It is for the governors of a foundation trust to appoint the chair. NHS Improvement is not involved in the recruitment of chairs of foundation trusts unless there is a breach of the licence. In the appointment of the Chair of Blackpool Trust the Chief Executive voluntarily stood down from all of the interview process prior to the appointment.<\/p> <\/p> The appointment of a Chief Executive in an NHS foundation trust is the responsibility of the trust\u2019s non-executive directors, including the chair, with approval from the Trust\u2019s council of governors<\/p>
Where trusts are facing challenges, it is right that NHS Improvement provides support and this can sometimes come in the form of shared leadership with nearby organisations.<\/p>
The arrangement that has been put in place for Blackpool is designed to deliver a number of benefits including:<\/p> - enhanced quality of care;<\/p> - financial sustainability; and<\/p> - improved performance.<\/p>
The Chief Executive of Blackpool NHS Trust and East Lancashire NHS Trust, Mr McGee will be paid a single salary. The process for agreeing the remuneration of the chief executive involves the agreement by the remuneration committees of each trust, in line with the organisational corporate governance procedures. The remuneration is in line with the NHS Improvement regulatory guidance on Very Senior Manager pay and was also approved by the Department in June 2019.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "894"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-21T12:49:19.58Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blackpool Teaching Hospitals NHS Foundation Trust: Public Appointments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what cognisance NHS Improvement took of the oral contribution of the Minister for Health of 27 June 2018, Official Report, column 1002, on irregularities of process that had taken place including at NHS Improvement in respect of the appointment process for the Chair of the Blackpool Trust, Pearse Butler, when NHS Improvement provided advice to that Trust on the permanent appointment of Kevin McGee as the Chief Executive of that Trust and to operate as Chief Executive of both the Blackpool Trust and the East Lancashire Hospitals Trust between June 2019 and September 2019.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/465", "label" : {"_value" : "Biography information for Gordon Marsden"}
}
, "tablingMemberConstituency" : {"_value" : "Blackpool South"}
, "tablingMemberPrinted" : [{"_value" : "Gordon Marsden"}
], "uin" : "893"}
, {"_about" : "http://data.parliament.uk/resources/1150218", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1150218/answer", "answerText" : {"_value" : "
There were a number of issues raised around the appointment process for the Chair of the Blackpool Trust on 27 June 2018. National Health Service foundation trusts operate within a clear accountability framework. It is for the governors of a foundation trust to appoint the chair. NHS Improvement is not involved in the recruitment of chairs of foundation trusts unless there is a breach of the licence. In the appointment of the Chair of Blackpool Trust the Chief Executive voluntarily stood down from all of the interview process prior to the appointment.<\/p> <\/p> The appointment of a Chief Executive in an NHS foundation trust is the responsibility of the trust\u2019s non-executive directors, including the chair, with approval from the Trust\u2019s council of governors<\/p>
Where trusts are facing challenges, it is right that NHS Improvement provides support and this can sometimes come in the form of shared leadership with nearby organisations.<\/p>
The arrangement that has been put in place for Blackpool is designed to deliver a number of benefits including:<\/p> - enhanced quality of care;<\/p> - financial sustainability; and<\/p> - improved performance.<\/p>
The Chief Executive of Blackpool NHS Trust and East Lancashire NHS Trust, Mr McGee will be paid a single salary. The process for agreeing the remuneration of the chief executive involves the agreement by the remuneration committees of each trust, in line with the organisational corporate governance procedures. The remuneration is in line with the NHS Improvement regulatory guidance on Very Senior Manager pay and was also approved by the Department in June 2019.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "893"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-21T12:49:19.627Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blackpool Teaching Hospitals NHS Foundation Trust and East Lancashire Hospitals NHS Trust: Pay"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether Kevin McGee will receive fill-time salaries for his each of his positions as Chief Executive of Blackpool Trust and East Lancashire Hospitals NHS Trust.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/465", "label" : {"_value" : "Biography information for Gordon Marsden"}
}
, "tablingMemberConstituency" : {"_value" : "Blackpool South"}
, "tablingMemberPrinted" : [{"_value" : "Gordon Marsden"}
], "uin" : "894"}
, {"_about" : "http://data.parliament.uk/resources/1149209", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1149209/answer", "answerText" : {"_value" : "
The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.<\/p> The Department\u2019s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p> https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a>.<\/p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.<\/p> <\/p> The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.<\/p> <\/p> Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this. <\/em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.<\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "402"}
, {"_value" : "403"}
, {"_value" : "405"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-21T13:06:43.637Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Radioisotopes: Imports"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the August 2019 British Nuclear Medicine Society's open letter to the Prime Minister on radioisotope delivery, what assessment his Department has made of the effect on the costs of radioisotope delivery of the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"}
}
, "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"}
, "tablingMemberPrinted" : [{"_value" : "Tom Brake"}
], "uin" : "400"}
, {"_about" : "http://data.parliament.uk/resources/1149333", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1149333/answer", "answerText" : {"_value" : " While Serious Shortage Protocols (SSP) in England have the scope to cover all medicines and appliances that are on a National Health Service prescription in primary care, including anti-epileptic drugs, it is clear that an SSP for therapeutic or generic equivalents will not necessarily be suitable for all medicines and patients. For example, where medicines need to be prescribed by brand for clinical reasons, which is the case for epilepsy medication.<\/p> Any protocol would only be introduced if clinicians with expertise in the relevant area think it is appropriate. Pharmacists will have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate or the patient should be referred to their prescriber.<\/p> The legislation enabling Ministers to issue SSPs was not introduced as a European Union exit measure alone but as a business-as-usual measure that can be used before and after our exit from the EU.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-21T13:07:33.52Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Epilepsy: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether anti-epileptic drugs are exempted from serious shortage protocols; and what assessment he has made of the potential effect of the use of such protocols on (a) people with learning disabilities and (b) their families in the event that the UK leaves the EU without a withdrawal agreement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "tablingMemberConstituency" : {"_value" : "North Norfolk"}
, "tablingMemberPrinted" : [{"_value" : "Norman Lamb"}
], "uin" : "475"}
, {"_about" : "http://data.parliament.uk/resources/1149339", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1149339/answer", "answerText" : {"_value" : " The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including those used for the treatment of epilepsy, once we have left the EU.<\/p> The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p> https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a><\/p>We have been working closely with suppliers to monitor over 300 different epilepsy medicines provided by almost 50 companies and we are pleased to see many are holding stockpiles far beyond the six weeks\u2019 additional buffer we requested. We also know that the vast majority of those suppliers with lower levels of stockpiles are taking action to re-route their supply chains away from the short straits crossings where applicable.<\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-10-21T13:04:06.75Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-10-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Epilepsy: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of anti-epilepsy medications in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "tablingMemberConstituency" : {"_value" : "North Norfolk"}
, "tablingMemberPrinted" : [{"_value" : "Norman Lamb"}
], "uin" : "479"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&max-ddpModified.=2019-10-21T13%3A36%3A02.031Z&answeringDeptSortName=Health+and+Social+Care&max-questionFirstAnswered.=2019-10-21T13%3A07%3A33.52Z", "page" : 0, "startIndex" : 1, "totalResults" : 13150, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|